A recent study from scientists at Northwestern University has revealed that two commonly prescribed drugs for treating type 2 ...

The American Academy of Pediatrics said aggressive obesity interventions would not fuel eating disorders. But authors of the ...

UNSW medical researchers say more Australians with type 2 diabetes need to be offered add-on medications that would better ...

Amid an ongoing debate over what role, if any, GLP-1 medications should play in treating children who are still in elementary ...

Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

The increasing popularity of these weight loss drugs is likely to shape how individuals approach food choices and meal ...

The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here's what doctors think ...

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are ...

ResMed's AirSense 11 platform and myAir app enhance patient engagement and efficiency. Check out why I remain bullish on RMD ...

For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 ...

GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...

I will say for the audience, we've already had dedicated episodes on sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 (GLP ... study, and another one, REALIZE-K, that's ...